Barclays PLC (BCS): Price and Financial Metrics


Barclays PLC (BCS)

Today's Latest Price: $5.53 USD

0.09 (1.65%)

Updated Oct 30 7:00pm

Add BCS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 44 in Foreign Banks

See all "A" rated Strong Buy stocks

BCS Stock Summary

  • BCS's went public 34.15 years ago, making it older than 92.22% of listed US stocks we're tracking.
  • For BCS, its debt to operating expenses ratio is greater than that reported by 97.79% of US equities we're observing.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 18.48 for Barclays Plc; that's greater than it is for 98.17% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Barclays Plc, a group of peers worth examining would be HGSH, BNS, NYCB, WBK, and NNI.
  • BCS's SEC filings can be seen here. And to visit Barclays Plc's official web site, go to www.home.barclays.

BCS Stock Price Chart Interactive Chart >

Price chart for BCS

BCS Price/Volume Stats

Current price $5.53 52-week high $10.22
Prev. close $5.44 52-week low $3.41
Day low $5.39 Volume 4,013,878
Day high $5.54 Avg. volume 4,564,938
50-day MA $5.34 Dividend yield N/A
200-day MA $5.87 Market Cap 23.98B

Barclays PLC (BCS) Company Bio


Barclays PLC is an international financial services provider engaged in personal, corporate and investment banking, credit cards and wealth management with an extensive presence in Europe, the Americas, Africa and Asia. The company was founded in 1896 and is based in London, United Kingdom.


BCS Latest News Stream


Event/Time News Detail
Loading, please wait...

BCS Latest Social Stream


Loading social stream, please wait...

View Full BCS Social Stream

Latest BCS News From Around the Web

Below are the latest news stories about Barclays Plc that investors may wish to consider to help them evaluate BCS as an investment opportunity.

BioCatch Secures $20 Million to Drive Innovation in Behavioral Biometrics

A new investment of $20 million takes the total capital raised by behavioral biometrics innovator BioCatch to more than $213 million. Participating in this week’s funding were a quartet of major global banks: Barclays, Citi, HSBC, and National Australia Bank (NAB). The funds add to BioCatch’s Series C round, which brought $145 million to the Read more… The post BioCatch Secures $20 Million to Drive Innovation in Behavioral Biometrics appeared first on Finovate .

Finovate | October 2, 2020

FTSE Russell’s Chinese government bond move heralds fresh opportunities for hedge fund investors

FTSE Russell’s Chinese government bond move heralds fresh opportunities for hedge fund investors Submitted By Hugh Leask | 01/10/2020 - 5:15pm FTSE Russell’s decision to include Chinese sovereign bonds in its flagship government bond index could offer hedge fund investors fresh alpha-generating and AUM-raising opportunities amid a wave of overseas capital inflows into the market. FTSE Russell said last month it intends to include Chinese sovereign bonds into its flagship World Government Bond Index from next year. The inclusion – which follows similar moves by Bloomberg Barclays and JP Morgan Chase, the other two main index compilers – tees up a range of investment opportunities for several hedge fund strategy types, industry observers said. Man Group, the London-listed global hedge fun...

Hedgeweek | October 1, 2020

Citigroup’s new stock-trading chief is cutting jobs in effort to revive the flagging business

The moves are just the first steps that Fater Belbachir, who joined Citigroup from Barclays last month to jump-start the firm's equities business, is expected to take.

CNBC | September 30, 2020

[BioCatch in Globes] Major banks invest $20m in biometrics co BioCatch

Israeli behavioral biometrics company BioCatch announced that four major global banks – Barclays, Citi, HSBC and National Australia Bank (NAB) – have invested $20 million in the company, expanding the company’s recent Series C financing round to $168 million raised. Read more here. The post [BioCatch in Globes] Major banks invest $20m in biometrics co BioCatch appeared first on OurCrowd Blog .

OurCrowd | September 30, 2020

Major Global Banks Invest $20 Million in BioCatch and Join American Express Ventures on New Client Innovation Board

NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--BioCatch, the global leader in behavioral biometrics, today announced that four major global banks – Barclays, Citi, HSBC and National Australia Bank (NAB) – have invested $20 million in the company, extending the company’s recent Series C fundraising round to a total of $168 million raised. In conjunction with the funding, BioCatch has established the BioCatch Client Innovation Board. The invitation-only Innovation Board will be a collaborative for

Business Wire | September 30, 2020

Read More 'BCS' Stories Here

BCS Price Returns

1-mo 10.38%
3-mo 5.53%
6-mo 7.80%
1-year -33.77%
3-year -37.98%
5-year -55.21%
YTD -39.96%
2019 31.86%
2018 -29.29%
2017 0.43%
2016 -12.88%
2015 -11.44%

Continue Researching BCS

Want to see what other sources are saying about Barclays Plc's financials and stock price? Try the links below:

Barclays Plc (BCS) Stock Price | Nasdaq
Barclays Plc (BCS) Stock Quote, History and News - Yahoo Finance
Barclays Plc (BCS) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8401 seconds.